Literature DB >> 29165928

How to solve the problem of hypersensitivity to asparaginase?

Ching-Hon Pui1,2, Yiwei Liu3, Mary V Relling3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29165928      PMCID： PMC5766401          DOI： 10.1002/pbc.26884

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN： 1545-5009            Impact factor:   3.167


× No keyword cloud information.
  10 in total

1.  Outcome of pediatric patients with acute lymphoblastic leukemia/lymphoblastic lymphoma with hypersensitivity to pegaspargase treated with PEGylated Erwinia asparaginase, pegcrisantaspase: A report from the Children's Oncology Group.

Authors:  Rachel E Rau; ZoAnn Dreyer; Mi Rim Choi; Wei Liang; Roman Skowronski; Krishna P Allamneni; Meenakshi Devidas; Elizabeth A Raetz; Peter C Adamson; Susan M Blaney; Mignon L Loh; Stephen P Hunger
Journal:  Pediatr Blood Cancer       Date:  2017-11-01       Impact factor: 3.167

2.  Analysis of Pre-existing IgG and IgM Antibodies against Polyethylene Glycol (PEG) in the General Population.

Authors:  Qi Yang; Timothy M Jacobs; Justin D McCallen; Dominic T Moore; Justin T Huckaby; Jasmine N Edelstein; Samuel K Lai
Journal:  Anal Chem       Date:  2016-11-16       Impact factor: 6.986

3.  Successful challenges using native E. coli asparaginase after hypersensitivity reactions to PEGylated E. coli asparaginase.

Authors:  C A Fernandez; E Stewart; J C Panetta; M R Wilkinson; A R Morrison; F D Finkelman; J T Sandlund; C H Pui; S Jeha; M V Relling; P K Campbell
Journal:  Cancer Chemother Pharmacol       Date:  2014-04-27       Impact factor: 3.333

4.  Rituximab in B-Lineage Adult Acute Lymphoblastic Leukemia.

Authors:  Sébastien Maury; Sylvie Chevret; Xavier Thomas; Dominik Heim; Thibaut Leguay; Françoise Huguet; Patrice Chevallier; Mathilde Hunault; Nicolas Boissel; Martine Escoffre-Barbe; Urs Hess; Norbert Vey; Jean-Michel Pignon; Thorsten Braun; Jean-Pierre Marolleau; Jean-Yves Cahn; Yves Chalandon; Véronique Lhéritier; Kheira Beldjord; Marie C Béné; Norbert Ifrah; Hervé Dombret
Journal:  N Engl J Med       Date:  2016-09-15       Impact factor: 91.245

5.  Postinduction dexamethasone and individualized dosing of Escherichia Coli L-asparaginase each improve outcome of children and adolescents with newly diagnosed acute lymphoblastic leukemia: results from a randomized study--Dana-Farber Cancer Institute ALL Consortium Protocol 00-01.

Authors:  Lynda M Vrooman; Kristen E Stevenson; Jeffrey G Supko; Jane O'Brien; Suzanne E Dahlberg; Barbara L Asselin; Uma H Athale; Luis A Clavell; Kara M Kelly; Jeffery L Kutok; Caroline Laverdière; Steven E Lipshultz; Bruno Michon; Marshall Schorin; Mary V Relling; Harvey J Cohen; Donna S Neuberg; Stephen E Sallan; Lewis B Silverman
Journal:  J Clin Oncol       Date:  2013-01-28       Impact factor: 44.544

6.  Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial.

Authors:  Ajay Vora; Nick Goulden; Rachel Wade; Chris Mitchell; Jeremy Hancock; Rachael Hough; Clare Rowntree; Sue Richards
Journal:  Lancet Oncol       Date:  2013-02-07       Impact factor: 41.316

7.  Outcomes Following Discontinuation of E. coli l-Asparaginase Upon Severe Allergic Reactions in Children With Acute Lymphoblastic Leukemia.

Authors:  Hsiu-Ju Yen; Wan-Hui Chang; Hsi-Che Liu; Ting-Chi Yeh; Giun-Yi Hung; Kang-Hsi Wu; Ching-Tien Peng; Yu-Hsiang Chang; Te-Kao Chang; Chih-Cheng Hsiao; Jiunn-Ming Sheen; Yu-Hua Chao; Tai-Tsung Chang; Shyh-Shin Chiou; Pei-Chin Lin; Shih-Chung Wang; Ming-Tsan Lin; Wan-Ling Ho; Yu-Chieh Chen; Der-Cherng Liang
Journal:  Pediatr Blood Cancer       Date:  2015-12-24       Impact factor: 3.167

8.  Role of the methoxy group in immune responses to mPEG-protein conjugates.

Authors:  Merry R Sherman; L David Williams; Monika A Sobczyk; Shawnya J Michaels; Mark G P Saifer
Journal:  Bioconjug Chem       Date:  2012-03-07       Impact factor: 4.774

9.  Activity and Toxicity of Intravenous Erwinia Asparaginase Following Allergy to E. coli-Derived Asparaginase in Children and Adolescents With Acute Lymphoblastic Leukemia.

Authors:  Lynda M Vrooman; Ivan I Kirov; ZoAnn E Dreyer; Michael Kelly; Nobuko Hijiya; Patrick Brown; Richard A Drachtman; Yoav H Messinger; A Kim Ritchey; Gregory A Hale; Kelly Maloney; Yuan Lu; Paul V Plourde; Lewis B Silverman
Journal:  Pediatr Blood Cancer       Date:  2015-09-16       Impact factor: 3.167

10.  A genome-wide association study identifies a novel susceptibility locus for the immunogenicity of polyethylene glycol.

Authors:  Chia-Jung Chang; Chien-Hsiun Chen; Bing-Mae Chen; Yu-Cheng Su; Ying-Ting Chen; Michael S Hershfield; Ming-Ta Michael Lee; Tian-Lu Cheng; Yuan-Tsong Chen; Steve R Roffler; Jer-Yuarn Wu
Journal:  Nat Commun       Date:  2017-09-12       Impact factor: 14.919
  10 in total
  4 in total

1.  Architectural Modification of Conformal PEG-Bottlebrush Coatings Minimizes Anti-PEG Antigenicity While Preserving Stealth Properties.

Authors:  Daniel Y Joh; Zackary Zimmers; Manav Avlani; Jacob T Heggestad; Hakan B Aydin; Nancy Ganson; Shourya Kumar; Cassio M Fontes; Rohan K Achar; Michael S Hershfield; Angus M Hucknall; Ashutosh Chilkoti
Journal:  Adv Healthc Mater       Date:  2019-03-25       Impact factor: 9.933

Review 2.  Clinical Utility of Pegaspargase in Children, Adolescents and Young Adult Patients with Acute Lymphoblastic Leukemia: A Review.

Authors:  Cynthia Bender; Luke Maese; Maria Carter-Febres; Anupam Verma
Journal:  Blood Lymphat Cancer       Date:  2021-04-19

Review 3.  Novel Insights on the Use of L-Asparaginase as an Efficient and Safe Anti-Cancer Therapy.

Authors:  Maaike Van Trimpont; Evelien Peeters; Yanti De Visser; Amanda M Schalk; Veerle Mondelaers; Barbara De Moerloose; Arnon Lavie; Tim Lammens; Steven Goossens; Pieter Van Vlierberghe
Journal:  Cancers (Basel)       Date:  2022-02-11       Impact factor: 6.639

4.  L-asparaginase doses number as a prognostic factor in childhood acute lymphoblastic leukemia: A survival analysis study.

Authors:  Amanda Cabral Dos Santos; Julia Maria Bispo Dos Santos; Elisangela da Costa Lima; Marcelo Gerardin Poirot Land
Journal:  Cancer Rep (Hoboken)       Date:  2021-08-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.